ArticleTranslational andrology and urology2026
Pembrolizumab in metastatic hormone-sensitive prostate cancer: lessons from the negative KEYNOTE-991 trial.
Jane McKenzie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleTranslational andrology and urology2026
Jane McKenzie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.